|
|
Volumn 12, Issue 8, 1998, Pages 533-537
|
|
The direct costs to the NHS of discontinuing and switching prescriptions for hypertension
a
a
|
|
Author keywords
Costs, discontinuing; Hypertension; Switching
|
|
Indexed keywords
AMILORIDE;
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BENDROFLUMETHIAZIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
CALCIUM ANTAGONIST;
CAPTOPRIL;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FOSINOPRIL;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE;
INDAPAMIDE;
LISINOPRIL;
METOPROLOL;
NICARDIPINE;
NIFEDIPINE;
OXPRENOLOL;
PROPRANOLOL;
RAMIPRIL;
TRIAMTERZIDE;
UNCLASSIFIED DRUG;
VERAPAMIL;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
DRUG COST;
DRUG FORMULARY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HOSPITAL COST;
HUMAN;
HYPERTENSION;
NATIONAL HEALTH SERVICE;
PATIENT COMPLIANCE;
SIDE EFFECT;
|
|
EID: 0031709156
PISSN: 09509240
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jhh.1000649 Document Type: Article |
|
Times cited : (62)
|
|
References (5)
|
